Critical Limb Ischemia clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
open to eligible people ages 45-99
This will be a randomized, placebo-controlled, parallel group, multicenter, Phase III study.The study aims to evaluate the Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects with Critical Limb Ischemia (CLI) with Minor Tissue Loss (Rutherford Category 5) who are Unsuitable for Revascularization.
Irvine, California and other locations
Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia
Sorry, in progress, not accepting new patients
This study will compare the effectiveness of best available surgical treatment with best available endovascular treatment in adults with critical limb ischemia (CLI) who are eligible for both treatment options.
Irvine, California and other locations
Last updated: